Evert J Barten Selected Research

Tumor Biomarkers (Tumor Markers)

10/2006

Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evert J Barten Research Topics

Disease

1	Infertility (Sterility) 01/2010
1	Obesity 01/2010
1	Testicular Neoplasms (Testicular Cancer) 01/2010
1	Hypospadias 01/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2006

Drug/Important Bio-Agent (IBA)

1	Diethylstilbestrol (Stilbestrol)FDA Link 01/2010
1	Pharmaceutical PreparationsIBA 01/2010
1	Tumor Biomarkers (Tumor Markers)IBA 10/2006
1	apaziquone (E 09)IBA 10/2006

Therapy/Procedure

1	Intravesical Administration 10/2006